A/Prof Alex Tan ~ JCU Associate Professor

Dr Alex Tan is a senior radiation oncologist at the Townsville Cancer Centre and the Icon Cancer Centre Mackay. He completed his medical degree at the University of Melbourne in 1999 and his specialist training in Radiation Oncology at the Peter MacCallum Cancer Centre in Melbourne in early 2008.

He then undertook a Research Fellowship with the Academic Urology Unit at the Institute of Cancer Research and the Royal Marsden Hospital in London, before returning to Australia to work at the Townsville Cancer Centre in 2009.

Dr Tan is passionate about advocating for regional and rural patients and improving and streamlining cancer treatment pathways for these patients. He is particularly interested in technology and the topic of motion management in radiotherapy.

Dr Tan is heavily involved in undergraduate and postgraduate education. He is a Phase 2 examiner with the Royal Australian and New Zealand College of Radiologists and Senior Lecturer at the James Cook University’s School of Medicine and Dentistry. He served as Director of Training at the Townsville Cancer Centre from 2013 to 2017.

He is active in clinical research as principal or co-investigator on a number of national and international trials. He is an active member of the Trans-Tasman Radiation Oncology Group (TROG), American Society for Radiation Oncology (ASTRO), the European Society for Radiotherapy and Oncology (ESTRO), the International Association for the Study of Lung Cancer (IASLC).

Interests

Research

• Organ and tumour motion in radiotherapy
• MRI-guided radiotherapy

Research Disciplines

• Oncology and carcinogenesis (3211)
• Clinical sciences (3202)

Socio-Economic Objectives

• Clinical health (2001)
• Evaluation of health and support services (2002)
• Provision of health and support services (2003)

These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.

Journal Articles

• Brown A, Yim J, Jones S, Tan A, Callander E, Watt K, De Abreu Lourenco R and Pain T (2023) Men’s perceptions and preferences regarding prostate cancer radiation therapy: A systematic scoping review. Clinical and Translational Radiation Oncology, 38. pp. 28-42
• Brown A, Tan A, Anable L, Callander E, De Abreu Lourenco R and Pain T (2022) Perceptions and recall of treatment for prostate cancer: A survey of two populations. Technical Innovations & Patient Support in Radiation Oncology, 24. pp. 78-85
• Brown A, Pain T, Tan A, Anable L, Callander E, Watt K, Street D and De Abreu Lourenco R (2022) Men's preferences for image-guidance in prostate radiation therapy: A discrete choice experiment. Radiotherapy and Oncology, 167. pp. 49-56
• Robards S, Brown A, Pain T, Patel D, Tan A and Carter H (2022) A value-based approach to prostate cancer image-guidance in a regional radiation therapy centre: a cost-minimisation analysis. Technical Innovations and Patient Support in Radiation Oncology, 24. pp. 131-136
• Ngoo A, Tan A, Mushaya C and Ho Y (2020) Short and long course neoadjuvant therapy compared for management of locally advanced rectal cancer: 11 years' experience at a regional centre. ANZ Journal of Surgery, 90 (5). pp. 812-820
• Patel D, Tan A, Brown A and Pain T (2020) Absence of prostate oedema obviates the need for delay between fiducial marker insertion and radiotherapy simulation. Journal of Medical Radiation Sciences, 67 (4). pp. 302-309
• Shanker M, Kim A, Brown A and Tan A (2020) Anatomical and dosimetric assessment of the prostate apex: a pilot comparison of image-guided transperineal ultrasound to conventional computed tomography simulation. Journal of Medical Imaging and Radiation Oncology, 64 (6). pp. 839-844
• Brown A, Tan A, Cooper S and Fielding A (2018) Obesity does not influence prostate intrafractional motion. Journal of Medical Radiation Sciences, 65 (1). pp. 31-38
• Oates R, Brown A, Tan A, Foroudi F, Joon M, Schneider M, Herschtal A and Kron T (2017) Real-time image-guided adaptive-predictive prostate radiotherapy using rectal diameter as a predictor of motion. Clinical Oncology, 29 (3). pp. 180-187

The map shows research collaborations by institution from the past 7 years.
Note: Map points are indicative of the countries or states that institutions are associated with.